Hybrid <i>in Silico</i> Drug Discovery Study toward the Development of Oral Antivirals for COVID-19-Reference-Cited by-同舟云学术

Hybrid <i>in Silico</i> Drug Discovery Study toward the Development of Oral Antivirals for COVID-19

Published:2022 Issue:2 Volume:21 Page:48-51
ISSN:1347-1767
Container-title:Journal of Computer Chemistry, Japan
language:en
Short-container-title:J. Comput. Chem. Jpn.

Author:

KOSHIMIZU Uika¹,ONO Junichi²,FUKUNISHI Yoshifum³,NAKAI Hiromi¹

Affiliation:

1. Department of Chemistry and Biochemistry, School of Advanced Science and Engineering, Waseda University,3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, JAPAN

2. Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, JAPAN

3. Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, 2-4-7 Aomi, Koto-ku, Tokyo 135-0064, JAPAN

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Society of Computer Chemistry Japan

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jccj/21/2/21_2022-0029/_pdf

Reference20 articles.

1. [1] World Health Organization, WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int/ (accessed on August 20, 2022).

2. [2] H. Wang, K. R. Paulson, S. A. Pease, S. Watson, H. Comfort, P. Zheng, et al., Lancet, 399, 1513 (2022). doi:10.1016/S0140-6736(21)02796-3 PMID:35279232

3. [3] A. Fernández-Castañeda, P. Lu, A. C. Geraghty, E. Song, M. H. Lee, J. Wood, et al., Cell, 185, 2452 (2022). doi:10.1016/j.cell.2022.06.008 PMID:35768006

4. [4] M. Cully, Nat. Rev. Drug Discov., 21, 3 (2022). doi:10.1038/d41573-021-00202-8 PMID:34857884

5. [5] A. Wu, Y. Wang, C. Zeng, X. Huang, S. Xu, C. Su, et al., Virus Res., 208, 56 (2015). doi:10.1016/j.virusres.2015.05.018 PMID:26036787